Mon, Dec 12, 2016
Kaustubh Chaubal, a Moody's Vice President and Senior Analyst said, "The drive for overseas expansion comes amid the consolidation of the global pharmaceutical industry, as drug companies look to boost their product and pipeline diversity, scale and pricing power."
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
